Treatment of Venous Thromboembolism in Real-Life Patients: A Nationwide, Population-Based Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 89,383
- 主要终点
- VTE hospitalization rate in VKA patients by sex
研究概览
简要总结
In a population of patients with venous thromboembolism and treated with oral anticoagulants (OAC) in routine clinical practice in Denmark this study will describe patients treated with each OAC
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients ≥ 18 years diagnosed with incident VTE at Danish public hospitals from 2006 through 2015
- •First-time (index) VTE will be defined as an in- or out-patient diagnosis of DVT or PE among patients redeeming a prescription for anticoagulant drugs within 30 days after index date
排除标准
- •In the analyses on type and duration of anticoagulant use, Patients with cancer will be excluded as they typically receive low molecular heparin directly from the hospital and their use of anticoagulants can therefore not be captured by redeemed prescriptions at pharmacies.
结局指标
主要结局
VTE hospitalization rate in VKA patients by sex
时间窗: Approximately 180 months
VTE hospitalization rate in VKA patients by age
时间窗: Approximately 180 months
VTE hospitalization rate in NOAC patients by age
时间窗: Approximately 180 months
Duration of Treatment in NOAC patients
时间窗: Approximately 180 months
Hospitalization rate in VKA patients for VTE
时间窗: Approximately 180 months
Hospitalization rate for first-time Venous thromboembolism (VTE) in Vitamin K antagonist (VKA) patients
Hospitalization rate in NOAC patients for VTE
时间窗: Approximately 180 months
Hospitalization rate for first-time venous thromboembolism in nonvitamin K antagonist oral anticoagulants (NOAC) patients
VTE hospitalization rate in NOAC patients by sex
时间窗: Approximately 180 months
Duration of treatment in VKA patients
时间窗: Approximately 180 months
次要结局
未报告次要终点